---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-096920"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2023-12-19T23:59:59+00:00"
generated_at: "2026-06-07T10:19:12.705827+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# China Pharma shareholders OK reverse split up to 1:10; NYSE compliance partially restored

## Summary
- Shareholders re-elected directors Bennett, Zhang, Dong; approved amendment to 2010 long-term incentive plan.
- Reverse stock split up to 1:10 approved; board retains discretion on whether and when to effect.
- NYSE American confirmed compliance with continued listing standards 1003(a)(ii) and (iii); non-compliance with Section 1003(f)(v) persists.
- Company remains under '.BC' indicator; NYSE may initiate delisting if non-compliance recurs within 12 months.

## SEC filing metadata
- accession: 0001213900-23-096920
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2023-12-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390023096920/0001213900-23-096920-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390023096920/ea190332-8k_chinapharm.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-096920
- JSON: https://secwatch.observer/filing/0001213900-23-096920.json
- Plain text: https://secwatch.observer/filing/0001213900-23-096920.txt

## Key facts
- Shareholder Votes
  CHINA PHARMA HOLDINGS, INC. shareholders approved Amend the Articles of Incorporation to effect a reverse stock split at a ratio of up to 1:10 at the 2023-12-17 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-12-17
  source text: 3. A proposal to amend the Company’s Articles of Incorporation to effect a reverse stock split at a ratio of up to 1:10, such that every holder of common stock, par value $0.001 per share, of the Company, shall receive one share of Common Stock for up to every ten shares of Common Stock held: Votes For Votes Against Abstentions 17,060,203 165,541 253 Pursuant to the foregoing votes, an amendment to the Company’s Articles of Incorporation to effect a reverse stock split at a ratio of up to 1:10, such that every holder of common stock, par value $0.001 per share, of the Company, shall receive one share of Common Stock for up to every ten shares of Common Stock held was approved and adopted.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1106644/000121390023096920/0001213900-23-096920-index.htm
- Shareholder Votes
  CHINA PHARMA HOLDINGS, INC. shareholders approved Adopt Amendment No.1 to the Amended and Restated 2010 Long-Term Incentive Plan at the 2023-12-17 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-12-17
  source text: 2. A proposal to adopt the Amendment No.1 to the Company’s Amended and Restated 2010 Long-Term Incentive Plan: Votes For Votes Against Abstentions 17,073,265 147,382 5,350 Pursuant to the foregoing votes, the Amendment No.1 to the Company’s Amended and Restated 2010 Long-Term Incentive Plan was approved and adopted.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1106644/000121390023096920/0001213900-23-096920-index.htm
- Shareholder Votes
  CHINA PHARMA HOLDINGS, INC. shareholders approved Election of three independent director nominees to the Board of Directors at the 2023-12-17 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-12-17
  source text: 1. A proposal to elect three independent director nominees to our Board of Directors: Independent Director’s Name Votes For Votes Withheld Gene Michael Bennett 17,174,742 51,255 Yingwen Zhang 17,165,245 60,752 Baowen Dong 17,165,232 60,765 Pursuant to the foregoing votes, Gene Michael Bennett, Yingwen Zhang and Baowen Dong were elected to serve as our independent directors until the next annual meeting and until their successors are elected and qualified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1106644/000121390023096920/0001213900-23-096920-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.